第一作者单位：[1]Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714)：
Wang Zhao,Gao Zhuo,Wang Yini,et al.SOLUBLE ST2 AND CD163 AS POTENTIAL BIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME[J].PEDIATRIC BLOOD & CANCER.2019,66:S50-S50.
APA：
Wang, Zhao,Gao, Zhuo,Wang, Yini,Wang, Jingshi&Zhang, Jia.(2019).SOLUBLE ST2 AND CD163 AS POTENTIAL BIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME.PEDIATRIC BLOOD & CANCER,66,
MLA：
Wang, Zhao,et al."SOLUBLE ST2 AND CD163 AS POTENTIAL BIOMARKERS TO DIFFERENTIATE PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FROM MACROPHAGE ACTIVATION SYNDROME".PEDIATRIC BLOOD & CANCER 66.(2019):S50-S50
